An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children

Background Respiratory Syncytial Virus (RSV) is the leading cause of acute lower respiratory infections (ALRI) in children. It is estimated to cause approximately 33.8 million new episodes of ALRI in children annually, 96% of these occurring in developing countries. It is also estimated to result in...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	BMC public health Ročník 11; číslo Suppl 3; s. S30
Hlavní autoři:	Nair, Harish, Verma, Vasundhara R, Theodoratou, Evropi, Zgaga, Lina, Huda, Tanvir, Simões, Eric AF, Wright, Peter F, Rudan, Igor, Campbell, Harry
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London BioMed Central 13.04.2011 Springer Nature B.V BMC
Témata:	Acute Disease Biostatistics Child Developing Countries Environmental Health Epidemiology Humans Immunization Immunization, Passive - economics Infants International policy LDCs Medical research Medicine Medicine & Public Health Pharmaceutical industry Public Health Respiratory Syncytial Virus Infections - prevention & control Respiratory Syncytial Virus Vaccines - economics Respiratory Syncytial Virus Vaccines - immunology Respiratory Syncytial Viruses - immunology Respiratory Tract Infections - prevention & control Respiratory Tract Infections - virology Streptococcus infections Studies Sustainability Vaccine Vaccines Vaccines, Attenuated - economics Vaccines, Attenuated - immunology Candidate Vaccine Palivizumab Passive Immunization Respiratory Syncytial Virus Respiratory Syncytial Virus Infection
ISSN:	1471-2458, 1471-2458
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!